Aggregation of actin and cofilin in identical twins with juvenile-onset dystonia

Ann Neurol. 2002 Oct;52(4):465-76. doi: 10.1002/ana.10319.

Abstract

The neuropathology of the primary dystonias is not well understood. We examined brains from identical twins with DYT1-negative, dopa-unresponsive dystonia. The twins exhibited mild developmental delays until age 12 years when they began developing rapidly progressive generalized dystonia. Genetic, metabolic, and imaging studies ruled out known causes of dystonia. Cognition was subnormal but stable until the last few years. Death occurred at ages 21 and 22 years. The brains were macroscopically unremarkable. Microscopic examination showed unusual glial fibrillary acidic protein-immunoreactive astrocytes in multiple regions and iron accumulation in pallidal and nigral neurons. However, the most striking findings were 1) eosinophilic, rod-like cytoplasmic inclusions in neocortical and thalamic neurons that were actin depolymerizing factor/cofilin-immunoreactive but only rarely actin-positive; and 2) abundant eosinophilic spherical structures in the striatum that were strongly actin- and actin depolymerizing factor/cofilin-positive. Electron microscopy suggested that these structures represent degenerating neurons and processes; the accumulating filaments had the same dimensions as actin microfilaments. To our knowledge, aggregation of actin has not been reported previously as the predominant feature in any neurodegenerative disease. Thus, our findings may shed light on a novel neuropathological change associated with dystonia that may represent a new degenerative mechanism involving actin, a ubiquitous constituent of the cytoskeletal system.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actin Depolymerizing Factors
  • Actins / analysis*
  • Adult
  • Cholinergic Antagonists / therapeutic use
  • Dystonic Disorders / drug therapy
  • Dystonic Disorders / metabolism*
  • Dystonic Disorders / pathology*
  • Family Health
  • Humans
  • Inclusion Bodies / chemistry
  • Inclusion Bodies / pathology
  • Inclusion Bodies / ultrastructure
  • Microfilament Proteins / analysis*
  • Microscopy, Electron
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / pathology
  • Neurons / chemistry
  • Neurons / pathology
  • Neurons / ultrastructure
  • Neuropil / chemistry
  • Neuropil / pathology
  • Neuropil / ultrastructure
  • Parasympatholytics / therapeutic use
  • Phenotype
  • Twins, Monozygotic

Substances

  • Actin Depolymerizing Factors
  • Actins
  • Cholinergic Antagonists
  • Microfilament Proteins
  • Parasympatholytics